Published mark
Labcorp
LABCORP HOLDINGS INC.
NYSE: LH. Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:a43b71a0-f368-4c60-bc78-16bea652a1df
- SEC CIK
- 0000920148
- Website
- www.labcorp.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- May 4, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Not published
- Chair
- Adam H. Schechter
- Independent
- 9 / 1010 directors published
- Published claims
- 505 distinct sources
- Evidence records
- 180 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 18 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
John H. Sampson seat on Labcorp, effective 2026-01-01.
EffectiveEffective Jan 1, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and Chief Information & Technology Officer | Akinbolade Oyegunwa | Not captured | unknown | Source reportedE4 |
| EVP, Chief Marketing Officer & Consumer Health Lead | Amy Summy | Not captured | unknown | Source reportedE5 |
| Executive Vice President & Chief Human Resources Officer | Anita Z. Graham | Not captured | unknown | Source reportedE6 |
| EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | Brian J. Caveney | Not captured | unknown | Source reportedE7 |
| Executive Vice President of Diagnostics | Bryan T. Vaughn | Not captured | unknown | Source reportedE8 |
| Vice President of Investor Relations | Christin O'Donnell | Not captured | unknown | Source reportedE9 |
| Executive Vice President of Operations | Jonathan C. Meltzer | Not captured | unknown | Source reportedE10 |
| Chief Financial Officer & Executive Vice President | Julia Wang | Not captured | unknown | Source reportedE11 |
| Executive Vice President, Chief Legal Officer & Corporate Secretary | Kathryn Wright Kyle | Not captured | unknown | Source reportedE12 |
| Enterprise Chief Scientific Officer & Senior Vice President | Marcia T. Eisenberg | Not captured | unknown | Source reportedE13 |
| Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer | Mark S. Schroeder | Not captured | unknown | Source reportedE14 |
| Executive VP and President of Central Laboratory Services & International Labcorp | Megan D. Bailey | Not captured | unknown | Source reportedE15 |
| Senior Vice President & Chief Accounting Officer | Peter J. Wilkinson | Not captured | unknown | Source reportedE16 |
Board of directors
Evidence10 directors published. 9 of 10 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Adam H. Schechter | Not independentChair | 2013 | None published | Source reportedE3 |
| Jeffrey A. Davis | Independent | 2019 | Audit, chairAudit · Chair; Quality and ComplianceQuality and Compliance | Source reportedE3 |
| John H. Sampson | Independent | 2026 | Quality and Compliance | Source reportedE3 |
| Kathryn E. Wengel | Independent | 2021 | Compensation and Human CapitalCompensation and Human Capital; Quality and ComplianceQuality and Compliance | Source reportedE3 |
| Kenneth J. Anderson | Independent | 2006 | AuditAudit; Nominating and Corporate GovernanceNominating and Corporate Governance | Source reportedE3 |
| Kirsten M. Kliphouse | Independent | 2022 | Audit | Source reportedE3 |
| Paul B. Rothman, M.D. | Independent | 2023 | None published | Source reportedE3 |
| Peter M. Neupert | Independent | 2013 | Nominating and Corporate Governance | Source reportedE3 |
| Richelle P. Parham | Independent | 2016 | Compensation and Human Capital, chairCompensation and Human Capital · Chair; Nominating and Corporate GovernanceNominating and Corporate Governance | Source reportedE3 |
| Victor Bulto | Independent | 2025 | Audit | Source reportedE3 |
| Garheng Kong | Independence not published | Not published | Compensation and Human CapitalNominating and Corporate Governance, chair | Source reportedE17 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Jeffrey A. Davis | Jeffrey A. Davis, Kenneth J. Anderson, Kirsten M. Kliphouse, Victor Bulto | Not described in the published record |
| Audit · Chair; Quality and Compliance | Not published | Jeffrey A. Davis | regulatory |
| Audit; Nominating and Corporate Governance | Not published | Kenneth J. Anderson | Not described in the published record |
| Compensation and Human Capital | Richelle P. Parham | Richelle P. Parham, Garheng Kong, Kathryn E. Wengel | human_capital, financial |
| Compensation and Human Capital · Chair; Nominating and Corporate Governance | Not published | Richelle P. Parham | human_capital, financial |
| Compensation and Human Capital; Quality and Compliance | Not published | Kathryn E. Wengel | human_capital, regulatory, financial |
| Nominating and Corporate Governance | Garheng Kong | Garheng Kong, Kenneth J. Anderson, Peter M. Neupert, Richelle P. Parham | Not described in the published record |
| Quality and Compliance | Not published | Jeffrey A. Davis, John H. Sampson, Kathryn E. Wengel | regulatory |
Committee RecordAudit: Chair Jeffrey A. Davis; Members Jeffrey A. Davis (Chair); Kenneth J. Anderson; Kirsten M. Kliphouse; Victor Bulto
Committee AppointmentJeffrey A. Davis: chair, Audit
Committee AppointmentKenneth J. Anderson: member, Audit
Committee AppointmentKirsten M. Kliphouse: member, Audit
Committee AppointmentVictor Bulto: member, Audit
Committee AppointmentRichelle P. Parham: chair, Compensation and Human Capital
Committee AppointmentGarheng Kong: member, Compensation and Human Capital
Committee AppointmentKathryn E. Wengel: member, Compensation and Human Capital
Committee RecordNominating and Corporate Governance: Chair Garheng Kong; Members Garheng Kong (Chair); Kenneth J. Anderson; Peter M. Neupert; Richelle P. Parham
Committee AppointmentGarheng Kong: chair, Nominating and Corporate Governance
Committee AppointmentKenneth J. Anderson: member, Nominating and Corporate Governance
Committee AppointmentPeter M. Neupert: member, Nominating and Corporate Governance
Committee AppointmentRichelle P. Parham: member, Nominating and Corporate Governance
Committee RecordQuality and Compliance: Chair not stated; Members Jeffrey A. Davis; John H. Sampson; Kathryn E. Wengel
Committee AppointmentJeffrey A. Davis: member, Quality and Compliance
Committee AppointmentJohn H. Sampson: member, Quality and Compliance
Committee AppointmentKathryn E. Wengel: member, Quality and Compliance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingLH (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: LH | current | Nov 1, 2004 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameLABCORP HOLDINGS INC.
Entity StatusPublic listing published
Official Websitehttps://www.labcorp.com
Published FactUS
Published FactHealthcare
Published FactMedical - Diagnostics & Research
Published Facthttps://www.labcorp.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Akinbolade OyegunwaExecutive Vice President and Chief Information & Technology Officercompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:19
- Amy SummyEVP, Chief Marketing Officer & Consumer Health Leadcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:20
- Anita Z. GrahamExecutive Vice President & Chief Human Resources Officercompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:21
- Brian J. CaveneyEVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officercompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:22
- Bryan T. VaughnExecutive Vice President of Diagnosticscompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:23
- Christin O'DonnellVice President of Investor Relationscompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:24
- Jonathan C. MeltzerExecutive Vice President of Operationscompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:25
- Julia WangChief Financial Officer & Executive Vice Presidentcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:26
- Kathryn Wright KyleExecutive Vice President, Chief Legal Officer & Corporate Secretarycompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:27
- Marcia T. EisenbergEnterprise Chief Scientific Officer & Senior Vice Presidentcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:28
- Mark S. SchroederExecutive Vice President, President of Diagnostics Laboratories & Chief Operating Officercompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:29
- Megan D. BaileyExecutive VP and President of Central Laboratory Services & International Labcorpcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:30
- Peter J. WilkinsonSenior Vice President & Chief Accounting Officercompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:31
- Adam H. SchechterChaircompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:9
- Jeffrey A. DavisIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:10
- John H. SampsonIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:11
- Kathryn E. WengelIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:12
- Kenneth J. AndersonIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:13
- Kirsten M. KliphouseIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:14
- Paul B. Rothman, M.D.Independent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:15
- Peter M. NeupertIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:16
- Richelle P. ParhamIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:17
- Victor BultoIndependent Directorcompany:a43b71a0-f368-4c60-bc78-16bea652a1df:leadership_role:18
- Garheng KongDirector (committee appointment)company:a43b71a0-f368-4c60-bc78-16bea652a1df:committee_record:37
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 18 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 6 Claims.
- E2LABCORP HOLDINGS INC. Form 10-K (filed 2026-02-24). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec proxy. Published Apr 10, 2026. Retrieved May 3, 2026. Cited by 10 Claims.
- E4other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E5other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E6other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E7other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E8other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E9other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E10other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E11other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E12other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E13other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E14other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E15other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E16other. Published May 4, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E17board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 18 Claims.
- E18Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- John H. Sampson seat on Labcorp, effective 2026-01-01.
- Victor Bulto seat on Labcorp, effective 2025-01-01.
- Paul B. Rothman, M.D. seat on Labcorp, effective 2023-01-01.
- Kirsten M. Kliphouse seat on Labcorp, effective 2022-01-01.
- Kathryn E. Wengel seat on Labcorp, effective 2021-01-01.
- Compensation and Human Capital; Quality and Compliance committee of Labcorp, effective 2021-01-01.
- Kathryn E. Wengel member of Compensation and Human Capital; Quality and Compliance, effective 2021-01-01.
- Jeffrey A. Davis seat on Labcorp, effective 2019-01-01.
- Audit · Chair; Quality and Compliance committee of Labcorp, effective 2019-01-01.
- Jeffrey A. Davis member of Audit · Chair; Quality and Compliance, effective 2019-01-01.
- Richelle P. Parham seat on Labcorp, effective 2016-01-01.
- Compensation and Human Capital · Chair; Nominating and Corporate Governance committee of Labcorp, effective 2016-01-01.
- Richelle P. Parham member of Compensation and Human Capital · Chair; Nominating and Corporate Governance, effective 2016-01-01.
- Adam H. Schechter seat on Labcorp, effective 2013-01-01.
- Adam H. Schechter chairs board Labcorp, effective 2013-01-01.
- Peter M. Neupert seat on Labcorp, effective 2013-01-01.
- Kenneth J. Anderson seat on Labcorp, effective 2006-01-01.
- Audit; Nominating and Corporate Governance committee of Labcorp, effective 2006-01-01.
- Kenneth J. Anderson member of Audit; Nominating and Corporate Governance, effective 2006-01-01.